Danaher CorpChange company Symbol lookupSelect an option...DHR Danaher CorpALHC Alignment Healthcare IncPRGS Progress Software CorpPMD Psychemedics CorpRPHM Reneo Pharmaceuticals IncDFSU Dimensional US Sustainability Core 1 ETFUNH UnitedHealth Group IncGURE Gulf Resources IncTDCX TDCX IncAMPX Amprius Technologies IncGo
Change company Symbol lookup
Select an option...
DHR Danaher Corp
ALHC Alignment Healthcare Inc
PRGS Progress Software Corp
PMD Psychemedics Corp
RPHM Reneo Pharmaceuticals Inc
DFSU Dimensional US Sustainability Core 1 ETF
UNH UnitedHealth Group Inc
GURE Gulf Resources Inc
TDCX TDCX Inc
AMPX Amprius Technologies Inc
Health Care : Life Sciences Tools & Services | Large Cap Blend
Company profileDanaher Corporation designs, manufactures and markets professional, medical, industrial, and commercial products and services. The Company’s segments include Biotechnology, which includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables and services; Life Sciences segment, which offers a range of instruments and consumables that are primarily used by customers to study the basic building blocks of life, including genes, proteins, metabolites, and cells, to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines; Diagnostics segment that offers clinical instruments, reagents, consumables, software, and services that hospitals, physicians’ offices, reference laboratories, and other critical care settings use to diagnose disease, and Environmental & Applied Solutions segment, which offers products and services that help protect precious resources and keep global food and water supplies safe.
|
|
|
|
| |
| Latest Earnings Beat Consensus (Q4 ending 12/2022) | Next Earnings Announcement | ||||||
|---|---|---|---|---|---|---|---|
| Q4 Non-GAAP earnings GAAP vs. Non-GAAP EarningsTD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. Announced January 24, 2023 | $2.87 | Q4 Consensus of 21 analysts | $2.55 | Difference from consensus | 12.77% | Q1 Earnings will announce | (Unconfirmed) April 25, 2023 |
Quarterly Earnings History and Estimates
Show high-low estimates
Draw trendlines
Draw up to 3 lines inside the chart.
DHR's fiscal year ends in December
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.
Information provided by Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.